Skip to main content
. 2023 Jun 7;158(8):807–815. doi: 10.1001/jamasurg.2023.1772

Figure 1. CONSORT Diagram of 548 Patients With Clinically Node-Positive Breast Cancer.

Figure 1.

Of 473 patients who received neoadjuvant systemic therapy, targeted axillary dissection (TAD) lymph nodes were successfully resected in 199 patients. In 80 of 199 patients (40.2%), TAD was followed by axillary lymph node dissection (ALND) whereas the other 119 patients (59.8%) underwent TAD alone. Follow-up data were available for all patients. SLNB indicates sentinel lymph node biopsy; TLNB, target lymph node biopsy.